Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Brain scans and imaging

Topic: Risk, prevention and care in population studies

BackgroundDeep-learning models predict mild cognitive impairment (MCI)-to-Alzheimers disease (AD) conversion from structural MRI with high accuracy. However, they are typically validated within a single cohort and judged on discrimination alone. Whether their risk scores are biologically grounded, and whether they generalise to independent data, remains unclear. MethodsWe applied the ADNI-trained Temporal Adaptive Fusion Network (TAF-Net), without retraining, to 101 MCI participants from OASIS-3 (25 converters, 76 stable) and tested whether its conversion-risk scores were grounded in independent structural, functional, and cognitive markers of AD. Regional atrophy rates were derived from longitudinal FreeSurfer, cognition from longitudinal MMSE and CDR-Sum-of-Boxes, and baseline resting-state functional connectivity from fMRIPrep, in structural and functional subsamples of 41 and 40 participants. Associations used rank-based statistics with false-discovery-rate correction. ResultsHigher TAF-Net risk tracked faster atrophy in medial-temporal AD-signature regions but not in AD-spared cortex -- an anatomically specific coupling that survived adjustment for global atrophy. In external validation, risk discriminated converters (AUC = 0.72), comparable to native atrophy and strongly concordant with it; atrophy statistically accounted for the models prognostic signal. Discrimination transferred but calibration did not: the two lowest tertiles of risk were assigned near-zero probability yet converted at 15%. Risk also tracked the multi-year rate of cognitive decline and, at baseline, was associated with reduced within-network functional-connectivity integrity, concentrated in salience and default-mode hubs; longitudinal functional analyses were underpowered. ConclusionsA conversion model trained on one cohort produced risk scores that, in an independent cohort, were grounded in the structural, functional, and cognitive hallmarks of Alzheimers disease -- supporting biological validity and external generalisation. The score, however, largely re-expresses the neurodegenerative substrate captured by structural atrophy. Rank ordering transferred across cohorts but absolute risk did not, so the score requires recalibration before its values can be interpreted as individual probabilities.

Key findings

Why it matters

This study tested a deep-learning model that predicts conversion from mild cognitive impairment to Alzheimer's disease using MRI, and found its risk scores tracked brain atrophy, cognitive decline, and functional connectivity changes. It is a validation of a prediction model, not a treatment, cure, or prevention.

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 4 of 10; How recent 5 of 5; Sample size 1 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year left out, no data; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 0 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 32 of the 94 points it could be judged on, which is 34 of 100. Raw total 34 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 34 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 34 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for randomised / blinded because the record does not state it. We have no data on impact for its field and year, so that was left out: it earned 32 of the 94 points we could judge it on, which is 34 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (medRxiv (preprint))
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 1 / 4 40 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Alireza Moayedikia: h-index 13 (OpenAlex, whole career)
Institution's track record 0 / 3 Swinburne University of Technology: institution h-index 509 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 32 / 94 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 32 of the 94 points we could judge it on is 34 out of 100.
Total 34 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Fin, S., & Moayedikia, A. (2026). Structural, Functional and Cognitive Validation of a Deep-Learning MCI-to-AD Conversion Model in OASIS-3. medRxiv (preprint). https://doi.org/10.64898/2026.09.05.26362318

Vancouver

Fin S, Moayedikia A. Structural, Functional and Cognitive Validation of a Deep-Learning MCI-to-AD Conversion Model in OASIS-3. medRxiv (preprint). 2026. doi:10.64898/2026.09.05.26362318.

BibTeX

@article{fin2026-bb8c3259,
  author  = {Fin, S. and Moayedikia, A.},
  title   = {{Structural, Functional and Cognitive Validation of a Deep-Learning MCI-to-AD Conversion Model in OASIS-3}},
  journal = {medRxiv (preprint)},
  year    = {2026},
  doi     = {10.64898/2026.09.05.26362318},
  url     = {https://doi.org/10.64898/2026.09.05.26362318}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.

Related studies in Brain scans and imaging

Also tagged “assessment”

840 studies in the library carry the topic tag “assessment”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.

Similar studies

More on Brain scans and imaging

See all studies in Brain scans and imaging →